Drug Shortage Report for APO-DILTIAZ CD

Last updated on 2025-12-05 History
Report ID 264552
Drug Identification Number 02229526
Brand name APO-DILTIAZ CD
Common or Proper name DILTIAZEM CD
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-08-06
Estimated end date 2025-12-05
Actual end date 2025-12-04
Shortage status Resolved
Updated date 2025-12-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2025-12-05 English Compare
v14 2025-12-04 French Compare
v13 2025-12-04 English Compare
v12 2025-11-27 French Compare
v11 2025-11-27 English Compare
v10 2025-11-20 French Compare
v9 2025-11-20 English Compare
v8 2025-10-24 French Compare
v7 2025-10-24 English Compare
v6 2025-09-18 French Compare
v5 2025-09-18 English Compare
v4 2025-08-28 French Compare
v3 2025-08-28 English Compare
v2 2025-08-07 French Compare
v1 2025-08-07 English Compare

Showing 1 to 15 of 15